Amicus Therapeutics, Inc. financial data

Symbol
FOLD on Nasdaq
Industry
Pharmaceutical Preparations
Location
47 Hulfish Street, Princeton, NJ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 295 % +3.88%
Quick Ratio 49.9 % +89.9%
Debt-to-equity 404 % -22.4%
Return On Equity -69.5 % +52.9%
Return On Assets -13.8 % +42%
Operating Margin 1.06 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 299M shares +1.9%
Common Stock, Shares, Outstanding 299M shares +2.76%
Entity Public Float 3.56B USD +19.4%
Common Stock, Value, Issued 2.94M USD +1.8%
Weighted Average Number of Shares Outstanding, Basic 305M shares +3.02%
Weighted Average Number of Shares Outstanding, Diluted 305M shares +3.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 494M USD +32.6%
Operating Income (Loss) 5.21M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -68.4M USD +63.7%
Income Tax Expense (Benefit) 36.3M USD
Net Income (Loss) Attributable to Parent -105M USD +39.7%
Earnings Per Share, Basic -0.34 USD/shares +42.4%
Earnings Per Share, Diluted -0.34 USD/shares +42.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 234M USD -11.3%
Marketable Securities, Current 16.1M USD -5.12%
Accounts Receivable, after Allowance for Credit Loss, Current 98.1M USD +33.7%
Inventory, Net 115M USD +103%
Assets, Current 498M USD +7.6%
Property, Plant and Equipment, Net 30.4M USD -2.04%
Operating Lease, Right-of-Use Asset 23.1M USD -21.6%
Intangible Assets, Net (Excluding Goodwill) 18M USD -15.4%
Goodwill 198M USD 0%
Other Assets, Noncurrent 18.7M USD -11.6%
Assets 787M USD +2.94%
Accounts Payable, Current 13.5M USD -41.8%
Employee-related Liabilities, Current 38.3M USD +49%
Liabilities, Current 158M USD -6.68%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 46.6M USD -11.1%
Other Liabilities, Noncurrent 13.5M USD +50.4%
Liabilities 608M USD -3.66%
Retained Earnings (Accumulated Deficit) -2.75B USD -3.95%
Stockholders' Equity Attributable to Parent 179M USD +34.2%
Liabilities and Equity 787M USD +2.94%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.7M USD -64.3%
Net Cash Provided by (Used in) Financing Activities -13.3M USD -70.1%
Net Cash Provided by (Used in) Investing Activities 7.54M USD -79.2%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 299M shares +2.76%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -37.3M USD -414%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 237M USD -11.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11.8M USD +3.87%
Deferred Tax Assets, Valuation Allowance 649M USD +2.69%
Deferred Tax Assets, Gross 659M USD -6.83%
Operating Lease, Liability 57.2M USD -4.87%
Payments to Acquire Property, Plant, and Equipment 1.81M USD -6.75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -72.9M USD +48.4%
Lessee, Operating Lease, Liability, to be Paid 89.8M USD -46.8%
Property, Plant and Equipment, Gross 57.1M USD +7.61%
Operating Lease, Liability, Current 8.54M USD +9.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.16M USD +6.18%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.24M USD -2.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -16.4%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.3M USD -88.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.21M USD +9.43%
Deferred Tax Assets, Operating Loss Carryforwards 321M USD +1.76%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.35M USD +9.1%
Amortization of Intangible Assets 800K USD
Depreciation, Depletion and Amortization 8.69M USD +24.1%
Share-based Payment Arrangement, Expense 83.8M USD -3.26%
Interest Expense 50.7M USD +24.3%